CDO1 and gastric cancer: First, an arising concern is that CDO1 probably plays distinct roles under specific conditions of GC, considering that it has been reported that activated ISR conferred resistance to cisplatin in GC cells [42] and our preliminary results have shown that patients with higher CDO1 expression had stronger resistance to the neoadjuvant chemotherapy SOX regimen (Data not shown).